QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)

NCT07131085 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER_GOV

Sponsor class

Conditions

MDS
AML

Interventions

DRUG: Allogeneic TCR-enhanced γδ T cell(QH101)
DRUG: Fludarabine (FLU)
DRUG: Cyclophosphamide (CTX)

Sponsor

Anhui Provincial Hospital